Vitreous Biomarkers for Proliferative Vitreoretinopathy Prognostication in Patients Undergoing Primary Retinal Detachment Repair. [PDF]
Shahlaee A+4 more
europepmc +1 more source
Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. [PDF]
Agarwal A+13 more
europepmc +1 more source
Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia <i>In Vitro</i>. [PDF]
Young AP+4 more
europepmc +1 more source
Anti-inflammatory potential of simvastatin and amfenac in ARPE-19 cells; insights in preventing re-detachment and proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery. [PDF]
Harju N+5 more
europepmc +1 more source
Mechanisms in proliferative vitreoretinopathy [PDF]
The wound-healing paradigm for proliferative vitreoretinopathy has provided numerous avenues for investigation into the pathobiology of the process. The emerging picture is a complex interaction of cytokines, matrix proteins, and metalloproteinases influencing cell behavior and resulting in the formation of undesirable periretinal membranes.
Jorge G. Arroyo, Ivana K. Kim
openaire +2 more sources
Related searches:
Anterior Proliferative Vitreoretinopathy
American Journal of Ophthalmology, 1988During a four-year period, 53 of 92 eyes (58%) undergoing vitreoretinal surgery for a retinal detachment with proliferative vitreoretinopathy demonstrated anterior proliferative vitreoretinopathy. We classified anterior proliferative vitreoretinopathy according to tractional direction, location, extent, and severity.
Thomas M. Aaberg, Hilel Lewis
openaire +3 more sources
Proliferative Vitreoretinopathy
2014Proliferative vitreoretinopathy is a sophisticated disease that complicates vitreoretinal pathologies like retinal detachments. Since its first description in the 1960s, we have learned a lot about this pathological entity; however, despite a large number of promising laboratory and clinical pharmacological research projects, we are still unable to ...
Carl, Claes, Anna Paula, Lafetá
openaire +2 more sources
Primary Retinectomy in Proliferative Vitreoretinopathy
American Journal of Ophthalmology, 2010To describe the functional and anatomic results of retinectomy without scleral buckling for anterior proliferative vitreoretinopathy in eyes that did not undergo previous buckling surgery.Retrospective, nonrandomized, interventional case series.We reviewed the results of 123 consecutive cases of retinectomy for rhegmatogenous retinal detachment ...
Tan HS+3 more
openaire +4 more sources
Proliferative Vitreoretinopathy
Ophthalmology, 1992To investigate the potential contribution of inflammatory and immune-mediated processes contributing to the pathogenesis of proliferative vitreoretinopathy (PVR), an immunohistochemical study was undertaken to characterize the infiltrating inflammatory cells in epiretinal membranes surgically removed from the eyes of patients with PVR.Twenty-one ...
Paul Hiscott+3 more
openaire +3 more sources
Die proliferative Vitreoretinopathie [PDF]
Die proliferative vitreoretinale Retinopathie (PVR) ist die schwerste Komplikation der vitreoretinalen Chirurgie. Die PVR ist durch eine komplexe zellulare Reaktion charakterisiert, die einer vitreoretinalen Wundheilungsreaktion entspricht und zu traktiven und durch Membranen fixierten Netzhautablosungen fuhrt.
P. Wiedemann, A. Bringmann
openaire +1 more source